There is a general inverse relationship in the resin of Cannabis between the amounts of THC present and the amount of the other principal cannabinoid, CBD. Whereas most drug strains contain primarily THC and little or no CBD, fiber and oilseed strains primarily contain CBD and very little THC. CBD can be converted to THC by acid catalyzed cyclization, and so could serve as a starting material for manufacturing THC. In theory, therefore, low-THC cultivars do not completely solve the problem of drug abuse potential. In practice, however, the illicit drug trade has access to easier methods of synthesizing THC or its analogues than by first extracting CBD from non-drug hemp strains.
The most pressing need of the hemp industry in North America is for the breeding of more productive oilseed cultivars. At present, mainly European cultivars are available, of which very few are suitable for specialized oilseed production. More importantly, hempseed oil is not competitive, except in the novelty niche market, with the popular food oils. As argued above, to be competitive, hemp should produce approximately 2 t/ha; at present 1 t/ha is considered average to good production. Doubling the productive capacity of a conventional crop would normally be considered impossible, but it needs to be understood just how little hemp has been developed as an oilseed. There may not even be extant land races of the kind of hemp oilseed strains that were once grown in Russia, so that except for a very few very recent oilseed cultivars, there has been virtually no breeding of oilseed hemp. Contrarily, hemp has been selected for fiber to the point that some breeders consider its productivity in this respect has already been maximized. Fiber strains have been selected for low seed production, so that most hemp germplasm has certainly not been selected for oilseed characteristics. By contrast, drug varieties have been selected for very high yield of flowers, and accordingly produce very high yield of seeds. Drug varieties have been observed to produce more than a kilogram of seed per plant, so that a target yield of several tonnes per hectare is conceivable (Watson and Clarke 1997). Of course, the high THC in drug cultivars makes these a difficult source of germplasm. However, wild plants of C. sativa have naturally undergone selection for high seed productivity, and are a particularly important potential source of breeding germplasm.

Years passed, and more studies rolled out with medically beneficial findings regarding cannabis until 2009 when Steep Hill Laboratory in Oakland, California, tested cannabis samples provided by Harborside Health Center to discover that a handful of cultivars contained more CBD than THC. This discovery kicked other labs into gear. They wanted to study medical cannabis to understand and potentially calibrate their cannabinoid ratios. Soon thereafter, laboratories uncovered CBD-dominant strains boasting 20:1 CBD to THC ratios, which opened up the cannabis market for a panoply of CBD products.


Dosage is important, because CBD can have side effects—the most common are tiredness, diarrhea, and changes in appetite and weight—so it’s best not to take more than you need. As CBD becomes more prevalent, says J. Michael Bostwick, M.D., a psychiatrist at Mayo Clinic in Rochester, MN, “I’m reasonably certain new kinds of side effects will emerge.”

Given its name, you might assume THCV shares psychoactive powers with its potent counterpart, THC. In reality, this cannabinoid is more like a cross between CBD and THC. From the former, it takes its modulating powers. Acting like THC “lite,” THCV like CBD can dampen the effects of a strong high. Yet at higher doses, THCV kicks into a psychoactive stimulant in its own right.
Peltz will be granted options to purchase 19.9 million common shares in the company at C$10.34 ($7.74) a share. The options will vest over a four-year period on a quarterly basis, and the vesting may accelerate if the company meet certain goals, including the consummation of certain defined transactions and the share price being at least at C$31.02 and C$41.36 for a specified number of trading days.

^ A 2016 review also found a statistically significant increase in crash risk associated with marijuana use, but noted that this risk was "of low to medium magnitude."[74] The increase in risk of motor vehicle crash for cannabis use is between 2 and 3 times relative to baseline, whereas that for comparable doses of alcohol is between 6 and 15 times.[75]
In some areas where cannabis use had been historically tolerated, new restrictions were instituted, such as the closing of cannabis coffee shops near the borders of the Netherlands,[222] and closing of coffee shops near secondary schools in the Netherlands.[223] In Copenhagen, Denmark in 2014, mayor Frank Jensen discussed possibilities for the city to legalize cannabis production and commerce.[224]
THC, an intoxicating and illegal substance, is responsible for causing marijuana users to get “high.” Unlike THC, CBD is non-psychoactive because it does not act on the same pathways as THC. Thus, it is impossible to get “high” by smoking or ingesting CBD or CBD oil extracted from industrial hemp plants, as they only have minuscule traces of THC (<0.3%).
Fibres are obtained by subjecting the stalks to a series of operations—including retting, drying, and crushing—and a shaking process that completes separation from the woody portion, releasing the long, fairly straight fibre, or line. The fibre strands, usually over 1.8 metres (5.8 feet) long, are made of individual cylindrical cells with an irregular surface. The fibre, longer and less flexible than flax, is usually yellowish, greenish, or a dark brown or gray and, because it is not easily bleached to sufficiently light shades, is rarely dyed. It is strong and durable and is used for cordage—e.g., twine, yarn, rope, cable, and string—and for artificial sponges and such coarse fabrics as sacking (burlap) and canvas. In Italy some hemp receives special processing, producing whitish colour and attractive lustre, and is used to make fabric similar to linen.

Not until the end of the 20th century was the specific mechanism of action of THC at the neuronal level studied.[citation needed] Researchers have subsequently confirmed that THC exerts its most prominent effects via its actions on two types of cannabinoid receptors, the CB1 receptor and the CB2 receptor, both of which are G protein-coupled receptors.[142] The CB1 receptor is found primarily in the brain as well as in some peripheral tissues, and the CB2 receptor is found primarily in peripheral tissues, but is also expressed in neuroglial cells.[143] THC appears to alter mood and cognition through its agonist actions on the CB1 receptors, which inhibit a secondary messenger system (adenylate cyclase) in a dose-dependent manner. These actions can be blocked by the selective CB1 receptor antagonist rimonabant (SR141716), which has been shown in clinical trials to be an effective treatment for smoking cessation, weight loss, and as a means of controlling or reducing metabolic syndrome risk factors.[144] However, due to the dysphoric effect of CB1 receptor antagonists, this drug is often discontinued due to these side effects.[145]
The overall effect is not assured because, like cannabis — which is illegal under U.S. federal law although some states have allowed medical or recreational use — states will continue to be able to enact laws related to industrial hemp, allowing for a potential patchwork of legislation across the country. Other questions remain in terms of how exactly the Agriculture Department will regulate the plant.
The overall effect is not assured because, like cannabis — which is illegal under U.S. federal law although some states have allowed medical or recreational use — states will continue to be able to enact laws related to industrial hemp, allowing for a potential patchwork of legislation across the country. Other questions remain in terms of how exactly the Agriculture Department will regulate the plant.
In 2015, almost half of the people in the United States had tried marijuana, 12% had used it in the past year, and 7.3% had used it in the past month.[31] In 2014, daily marijuana use amongst US college students had reached its highest level since records began in 1980, rising from 3.5% in 2007 to 5.9% in 2014 and had surpassed daily cigarette use.[251]
^ Housman & Dorman 2005, pp. 303–04. "The linear model supported previous findings, including regular exercise, limited alcohol consumption, abstinence from smoking, sleeping 7–8 hours a night, and maintenance of a healthy weight play an important role in promoting longevity and delaying illness and death." Citing Wingard DL, Berkman LF, Brand RJ (1982). "A multivariate analysis of health-related practices: a nine-year mortality follow-up of the Alameda County Study". Am J Epidemiol. 116 (5): 765–75. doi:10.1093/oxfordjournals.aje.a113466. PMID 7148802.

Experimental studies have also been conducted in order to assess the effect of cannabis use on schizophrenia. D’Souza et al. (2004) administered varying levels of the main ingredient in cannabis to healthy individuals with a history of cannabis exposure (but not abuse) and found that the subjects in the study displayed both positive and negative symptoms associated with schizophrenia, although all symptoms disappeared by about 3 h. D’Souza et al. (2005) conducted a follow-up study in which they followed the same protocol, but with clinically stable schizophrenia patients. Again, they found brief increases in positive symptoms, even if the patients were already taking antipsychotics.


Cannabis research suggests medical marijuana could become an effective treatment for diabetic neuropathy. Diabetic neuropathy is a debilitating and sometimes fatal condition caused by diabetes. Diabetics suffer from high blood sugar due to insulin resistance, and this damages nerve cells in the body, causing severe pain. Patients who consumed THC as part of a study found they experienced less pain. Findings are not definitive, however, and further research into cannabis as a treatment for diabetes and associated symptoms is required.
I will continue to use bluebird botanical products loyally. Their customer service is exceptional. Their products are of exceptional quality and reasonably priced. Due to the dedication of their staff, I have been given back something I thought was lost to me: HOPE. I cannot thank BlueBird enough for their dedication to sharing a product that improves the quality of life for others.
Returning to our CBD article, Dr. Jean Talleyrand, founder and Chief Medical Officer of MediCann in Oakland, California, and co-founder and Chief Medical Officer of The Clinical Endocannabinoid System Consortium in San Diego, California, emphasizes that any “product should be evaluated for its packaging, shelf life, and variance,” as well as third-party testing, which will show strength and purity.
Cannabis is by far the most widely cultivated, trafficked and abused illicit drug. Half of all drug seizures worldwide are cannabis seizures. The geographical spread of those seizures is also global, covering practically every country of the world. About 147 million people, 2.5% of the world population, consume cannabis (annual prevalence) compared with 0.2% consuming cocaine and 0.2% consuming opiates. In the present decade, cannabis abuse has grown more rapidly than cocaine and opiate abuse. The most rapid growth in cannabis abuse since the 1960s has been in developed countries in North America, Western Europe and Australia. Cannabis has become more closely linked to youth culture and the age of initiation is usually lower than for other drugs. An analysis of cannabis markets shows that low prices coincide with high levels of abuse, and vice versa. Cannabis appears to be price-inelastic in the short term, but fairly elastic over the longer term. Though the number of cannabis consumers is greater than opiate and cocaine consumers, the lower prices of cannabis mean that, in economic terms, the cannabis market is much smaller than the opiate or cocaine market.
×